Growth Metrics

LifeStance Health (LFST) Receivables - Net (2021 - 2025)

LifeStance Health (LFST) has disclosed Receivables - Net for 5 consecutive years, with $95.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Receivables - Net fell 27.38% to $95.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $95.7 million, a 27.38% decrease, with the full-year FY2025 number at $95.7 million, down 27.38% from a year prior.
  • Receivables - Net was $95.7 million for Q4 2025 at LifeStance Health, down from $121.1 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $175.9 million in Q1 2024 to a low of $60.1 million in Q2 2021.
  • A 5-year average of $118.4 million and a median of $121.1 million in 2025 define the central range for Receivables - Net.
  • Peak YoY movement for Receivables - Net: surged 66.04% in 2022, then fell 27.38% in 2025.
  • LifeStance Health's Receivables - Net stood at $76.1 million in 2021, then surged by 32.58% to $100.9 million in 2022, then increased by 24.33% to $125.4 million in 2023, then rose by 5.1% to $131.8 million in 2024, then dropped by 27.38% to $95.7 million in 2025.
  • Per Business Quant, the three most recent readings for LFST's Receivables - Net are $95.7 million (Q4 2025), $121.1 million (Q3 2025), and $129.5 million (Q2 2025).